Linda S Grais Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Linda S Grais.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Linda S Grais. Linda S Grais is Director in ARCA biopharma, Inc. ($ABIO) and President and CEO in Ocera Therapeutics, Inc. ($TZYM) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN) and Director in PRA Health Sciences, Inc. ($PRAH) and Director in Corvus Pharmaceuticals, Inc. ($CRVS).
Latest Insider Trading Transactions of Linda S Grais
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABIO, CRVS, TZYM, PRAH, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Grais Linda | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | Grais Linda S | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K | |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | Grais Linda S | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K | |
| Jun 12 2020 | CRVS | Corvus Pharmaceuti ... | Grais Linda S | Director | Option Exercise | A | 3.27 | 15,000 | 49,050 | 15,000 | |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | Grais Linda S | Director | Option Exercise | A | 1.01 | 15,000 | 15,150 | 15,000 | |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | Grais Linda S | Director | Option Exercise | A | 1.01 | 15,000 | 15,150 | 15,000 | |
| May 20 2020 | PRAH | PRA Health Science ... | Grais Linda S | Director | Grant | A | 0.00 | 1,324 | 0 | 9,433 | 8.1 K to 9.4 K (+16.33 %) |
| Mar 23 2020 | CRVS | Corvus Pharmaceuti ... | Grais Linda S | Director | Option Exercise | A | 2.00 | 15,000 | 30,000 | 15,000 | |
| Jun 24 2019 | CRVS | Corvus Pharmaceuti ... | Grais Linda S | Director | Option Exercise | A | 3.61 | 15,000 | 54,150 | 15,000 | |
| Jun 05 2019 | PRAH | PRA Health Science ... | Grais Linda S | Director | Grant | A | 0.00 | 1,436 | 0 | 8,109 | 6.7 K to 8.1 K (+21.52 %) |
| Jan 30 2019 | CRVS | Corvus Pharmaceuti ... | Grais Linda S | Director | Option Exercise | A | 3.88 | 30,000 | 116,400 | 30,000 | |
| Jan 16 2019 | ZSAN | Zosano Pharma Corp | Grais Linda S | Director | Option Exercise | A | 2.56 | 25,000 | 64,000 | 25,000 | |
| Jun 25 2018 | PRAH | PRA Health Science ... | Grais Linda S | Director | Grant | A | 0.00 | 1,307 | 0 | 6,673 | 5.4 K to 6.7 K (+24.36 %) |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 11,969 | 8,019 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 30,827 | 20,654 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 30,826 | 20,653 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 7.84 | 37,500 | 294,000 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 7.38 | 491,550 | 3,627,639 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 3.76 | 160,000 | 601,600 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 2.98 | 348,600 | 1,038,828 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 2.15 | 289,200 | 621,780 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Sell | D | 1.52 | 70,000 | 106,400 | 0 | 70 K to 0 (-100.00 %) |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Sell | D | 1.52 | 230,000 | 349,600 | 0 | 230 K to 0 (-100.00 %) |
| Jul 14 2017 | PRAH | PRA Health Science ... | Grais Linda S | Director | Grant | A | 0.00 | 1,318 | 0 | 5,366 | 4 K to 5.4 K (+32.56 %) |
| Mar 30 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Grant | A | 0.00 | 230,000 | 0 | 300,000 | 70 K to 300 K (+328.57 %) |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 2.50 | 8,000 | 20,000 | 8,000 | |
| Dec 16 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 2.15 | 289,200 | 621,780 | 289,200 | |
| Dec 08 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 2.14 | 7,000 | 14,980 | 70,000 | 63 K to 70 K (+11.11 %) |
| Jun 20 2016 | PRAH | PRA Health Science ... | Grais Linda S | Director | Grant | A | 0.00 | 1,466 | 0 | 4,048 | 2.6 K to 4 K (+56.78 %) |
| Mar 07 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 3.19 | 3,000 | 9,570 | 63,000 | 60 K to 63 K (+5.00 %) |
| Feb 16 2016 | ABIO | ARCA biopharma, In ... | Grais Linda S | Director | Option Exercise | A | 3.44 | 8,000 | 27,520 | 8,000 | |
| Jan 25 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 2.38 | 10,000 | 23,800 | 60,000 | 50 K to 60 K (+20.00 %) |
| Jan 19 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 2.08 | 10,000 | 20,800 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jan 07 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 2.98 | 116,200 | 346,276 | 116,200 | |
| Jan 07 2016 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 2.98 | 348,600 | 1,038,828 | 348,600 | |
| Oct 13 2015 | PRAH | PRA Health Science ... | Grais Linda S | Director | Grant | A | 0.00 | 2,582 | 0 | 2,582 | 0 to 2.6 K |
| Jun 22 2015 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | A | 3.76 | 160,000 | 601,600 | 160,000 | |
| May 06 2015 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Buy | P | 3.73 | 30,000 | 111,900 | 40,000 | 10 K to 40 K (+300.00 %) |
Page: 1